Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Technical Analysis

689 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ligand Pharma’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is -1.68, suggesting Ligand Pharma is a Buy.
Ligand Pharma’s (LGND) 20-Day exponential moving average is 62.99, while Ligand Pharma’s (LGND) share price is $58.86, making it a Sell.
Ligand Pharma’s (LGND) 50-Day exponential moving average is 65.63, while Ligand Pharma’s (LGND) share price is $58.86, making it a Sell.

Ligand Pharma (LGND) Pivot Points

Sep 26, 2023, 12:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
56.72
57.91
58.62
59.81
60.51
61.70
62.40
Fibonacci
57.91
58.63
59.08
59.81
60.53
60.98
61.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Sep 26, 2023, 12:19 PM
Period
Simple
Exponential
MA5
61.06Sell
60.54Sell
MA10
61.87Sell
61.61Sell
MA20
63.32Sell
62.99Sell
MA50
65.68Sell
65.63Sell
MA100
69.95Sell
67.88Sell
MA200
70.38Sell
68.26Sell
Ligand Pharma’s (LGND) 10-Day exponential moving average is 61.61, while Ligand Pharma’s (LGND) share price is $58.86, making it a Sell.
Ligand Pharma’s (LGND) 100-Day exponential moving average is 67.88, while Ligand Pharma’s (LGND) share price is $58.86, making it a Sell.
Ligand Pharma’s (LGND) stock price is $58.86 and Ligand Pharma’s (LGND) 50-day simple moving average is 65.68, creating a Sell signal.
Ligand Pharma’s (LGND) stock price is $58.86 and Ligand Pharma’s (LGND) 100-day simple moving average is 69.95, creating a Sell signal.
Ligand Pharma’s (LGND) stock price is $58.86 and Ligand Pharma’s (LGND) 200-day simple moving average is 70.38, creating a Sell signal.

Ligand Pharma (LGND) Technical Indicators

Sep 26, 2023, 12:19 PM
Name
Value
Implied Action
RSI (14)
29.23
Buy
STOCH (9,6)
4.88
Buy
STOCHRSI (14)
3.02
Buy
MACD (12,26)
-1.68
Buy
ADX (14)
20.24
Neutral
Williams %R
-94.64
Buy
CCI (14)
-188.87
Buy
ATR (14)
1.60
-
Ultimate Oscillator
33.94
Neutral
ROC
-11.21
Sell
Ligand Pharma’s (LGND) Relative Strength Index (RSI) is 29.23, creating a Buy signal.
Ligand Pharma’s (LGND) Trend Strength Indicator (ADX) is 20.24, creating a Neutral signal.
Ligand Pharma’s (LGND) Commodity Channel Index (CCI) is -188.87, creating a Buy signal.
Ligand Pharma’s (LGND) Price Rate of Change (ROC) is -11.21, creating a Sell signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Sell.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 29.23, which suggests LGND is a Buy.
      What is LGND’s MACD?
      LGND’s MACD is -1.68, which suggests LGND is a Buy.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 61.06, which suggests LGND is a Sell.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 63.32, which suggests LGND is a Sell.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 65.68, which suggests LGND is a Sell.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 70.38, which suggests LGND is a Sell.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -94.64, which suggests LGND is a Buy.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is -188.87, which suggests LGND is a Buy.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis